apoC-III Antibodies

Santa Cruz Biotechnology provides a broad selection of apoC-III Antibodies for research in lipid metabolism and cardiovascular health. apoC-III Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein C-III (apoC-III) plays a crucial role in lipid transport and metabolism, influencing triglyceride levels and contributing to the regulation of lipoprotein metabolism. Elevated levels of apoC-III are associated with an increased risk of cardiovascular diseases, making it an important target for research in understanding lipid disorders and developing therapeutic strategies. ApoC-III research has revealed significant insights into cardiovascular disease mechanisms and potential treatment approaches. Understanding apoC-III function and regulation continues to advance knowledge in lipid metabolism disorders. Recent studies have highlighted apoC-III as a promising therapeutic target for managing cardiovascular conditions. The extensive selection of monoclonal apoC-III antibodies from Santa Cruz Biotechnology enables researchers worldwide to advance scientific understanding of cardiovascular health and disease mechanisms.